Telix Opens Australian Manufacturing Facility to Expand Radiopharmaceutical Production and Cancer Treatment

Telix opens radiopharmaceutical facility in Australia for cancer treatment

Known as Telix Manufacturing Solutions North Melbourne (TMSNM), the site is described as the country’s first purpose-built facility to combine radiochemistry laboratories, clinical manufacturing, patient dose administration, and The post Telix opens radiopharmaceutical facility in Australia for cancer treatment appeared first on Pharmaceutical Business review.

Telix opens Australian manufacturing facility to expand radiopharmaceutical production and cancer treatment

Telix Pharmaceuticals has officially opened a new radiopharmaceutical research and manufacturing facility in Melbourne, saying the investment will expand Australia's sovereign manufacturing capability while supporting the development and delivery of new cancer treatments.

Telix opens Australian-first radiopharmaceutical facility

MELBOURNE, Australia, July 16, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today officially opens a multi-million dollar radiopharmaceutical research, manufacturing and treatment facility in Melbourne, expanding and strengthening Australia's capability in one of the world's fastest-growing areas of cancer diagnosis and treatment. Telix Manufacturing Solutions North Melbourne (TMSNM) is a purpose-built site…

Telix Opens Australian-First Facility to Accelerate Delivery of New Cancer Treatments and Expand Sovereign Manufacturing

Telix Opens Australian-First Facility to Accelerate Delivery of New Cancer Treatments and Expand Sovereign Manufacturing Melbourne (Australia) and Indianapolis, IN (United States) | July 16, 2026 First-of-its-kind facility in Australia where radiopharmaceuticals are developed, manufactured and administered to patients under one roof. Patient care and research delivered in collaboration with the Melbourne Theranostic Innovation Centre (MTIC), …